Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMCM5Z1)

Drug Name
BAY1097761 Drug Info
Synonyms Adrenomedullin Pegol; PEG-ADM
Indication
Disease Entry ICD 11 Status REF
Acute respiratory distress syndrome CB00 Phase 2 [1]
Respiratory distress syndrome CB00 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMCM5Z1

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Adrenomedullin (ADM) TTV14YH ADML_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT04417036) Safety and Efficacy of Inhaled Pegylated Adrenomedullin (PEG-ADM) in Patients Suffering From Acute Respiratory Distress Syndrome (ARDS): a Double-blind, Randomized, Placebo-controlled, Multicenter Phase 2a/b Clinical Trial. U.S.National Institutes of Health.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight